Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 21.12.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
21.12.23Shape Robotics A/S: Shape Robotics expects significant growth - guidance for 202449Company announcement no. 43-23 Copenhagen, Dec 21, 2023 The announcement contains inside information. Guidance 2024 Revenue DKK 300-325 million EBITDA DKK 14-18...
► Artikel lesen
21.12.23Ziccum AB: CEO's Seasons Greetings 2023: A pivotal year of significant results78At the end of an exciting and eventful year, Ziccum CEO Ann Gidner summarizes the milestones reached, the robust Ziccum Strategic roadmap underpinning them and looks forward to a busy and dynamic 2024. Dear...
► Artikel lesen
21.12.23The NFT Gaming Company, Inc. Launches Artificial Intelligence (AI) Game, Jigsaw Puzzle AI, on Apple and Google Play435Roseland, NJ, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The NFT Gaming Company, Inc. ("NFTG" or the "Company"), a company developing a digital gaming platform and community that will offer users the ability...
► Artikel lesen
21.12.23Global Hydrogen Energy LLC Completes Business Combination with Dune Acquisition Corporation to Form Publicly Traded Global Gas Corporation509Pure Play Hydrogen and Carbon Recovery Project Developer and Industrial Gas SupplierGlobal Gas is a Founder-Led, Minority-Owned BusinessAll Existing Global Hydrogen Equityholders to Roll 100% of their...
► Artikel lesen
21.12.23Par Pacific Holdings, Inc.: Par Pacific Announces 2024 Capital Expenditure Guidance269HOUSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) ("Par Pacific") today announced its 2024 capital expenditure and turnaround outlay guidance with a range of $220...
► Artikel lesen
21.12.23Linkage Global Inc Announces Closing of $6,000,000 Initial Public Offering209Tokyo Japan, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Linkage Global Inc (the "Company" or "Linkage"), a cross-border e-commerce integrated service company headquartered in Japan, today announced the closing...
► Artikel lesen
21.12.23Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)141NOVATO, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
► Artikel lesen
21.12.23Presidio Property Trust, Inc.: Presidio Regains Compliance with Nasdaq Minimum Bid Price Requirement230SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. ("Presidio" or the "Company") (NASDAQ: SQFT; SQFTP; SQFTW), an internally managed, diversified real estate investment trust...
► Artikel lesen
21.12.23AlphaTime Acquisition Corp.: Alphatime Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders31New York, New York, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Alphatime Acquisition Corp (Nasdaq: ATMC, ATMCU, ATMCR, and ATMCW) (the "Company") announced today that the Company's Extraordinary General Meeting...
► Artikel lesen
21.12.23Stifel Financial Corporation: Stifel Reports November 2023 Operating Data148ST. LOUIS, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for November 30, 2023 in an effort to provide timely information to investors...
► Artikel lesen
21.12.23Galecto, Inc.: Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis340BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced...
► Artikel lesen
21.12.23AAR Corp: AAR reports second quarter fiscal year 2024 results219Second quarter sales of $545 million, up 16% over the prior yearSecond quarter GAAP diluted earnings per share from continuing operations of $0.67, compared to $0.64 in Q2 FY2023Record second quarter...
► Artikel lesen
21.12.23Incannex Healthcare: Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia246Highlights: Incannex subsidiary, Clarion Clinics, has received Human Research Ethics Committee (HREC) endorsement for administration of psychedelic-assisted therapies for TRD and PTSD.HREC approval...
► Artikel lesen
21.12.23Mission Produce, Inc.: Mission Produce Announces Fiscal 2023 Fourth Quarter Financial Results190OXNARD, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (Nasdaq: AVO) ("Mission" or the "Company"), a world leader in sourcing, producing, and distributing fresh Hass avocados with...
► Artikel lesen
21.12.23Hudson Acquisition I Corp. Receives Notification from Nasdaq Regarding Minimum Market Value Deficiency81NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hudson Acquisition I Corp. (the "Company" or "Hudson") (Nasdaq: HUDA), announced today that it received a notice (the "Notice") from the Listing Qualifications...
► Artikel lesen
21.12.23Mineralys Therapeutics, Inc.: Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension137- Topline data from confirmatory Launch-HTN trial expected in 2H 2025 - - Topline data from ongoing Advance-HTN pivotal trial expected in 2H 2024 - RADNOR, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mineralys...
► Artikel lesen
21.12.23Banzai International, Inc.: Banzai CEO Purchases Additional Shares in Market242SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales...
► Artikel lesen
21.12.23Vor Biopharma: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)122CAMBRIDGE, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of December 20, 2023, the Compensation...
► Artikel lesen
21.12.23Cemtrex Inc.: Cemtrex Reports Unaudited Fourth Quarter and Full Fiscal Year 2023 Financial Results333Fiscal Full Year 2023 Revenue Increased 33% to $59.7M Fiscal Full Year 2023 Gross Margin up 680 Basis Points to 44% Management to Host Conference Call Today at 5:00 p.m. ET Brooklyn, NY, Dec. 21...
► Artikel lesen
21.12.23Hyloris Pharmaceuticals SA: Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome178Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome Equal Partnership with AFT Pharmaceuticals for Development of a Novel Locally-Acting Product Candidate in Burning Mouth...
► Artikel lesen
Seite:  Weiter >>